ER
PFE icon

Enlightenment Research’s Pfizer PFE Stock Holding History

Enlightenment Research’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,200
Closed -$1.06M – 66
2022
Q3 		$1.06M Buy
+24,200
New +$1.18M 2.34% 6
2021
Q4 		– Sell
-8,600
Closed -$370K – 181
2021
Q3 		$370K Buy
8,600
+1,200
+16% +$53.2K 0.45% 77
2021
Q2 		$290K Buy
+7,400
New +$288K 0.37% 87
2020
Q1 		– Sell
-23,820
Closed -$885K – 187
2019
Q4 		$885K Buy
23,820
+3,899
+20% +$139K 4.15% 5
2019
Q3 		$679K Sell
19,921
-2,424
-11% -$88.1K 1.51% 17
2019
Q2 		$861K Buy
+22,345
New +$887K 0.44% 61

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Enlightenment Research's PFE Position: Q4 2022 in Review

Enlightenment Research sold out of Pfizer (PFE) in Q4 2022, closing a stake of 24,200 shares — an estimated $1.06M sold.

Enlightenment Research first reported a position in PFE in Q2 2019 and held it in 6 quarters. The position peaked at $1.06M in Q3 2022. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Enlightenment Research reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Enlightenment Research sold 24,200 Pfizer shares in Q4 2022, an estimated $1.06M.
  • Enlightenment Research first reported a position in Pfizer in Q2 2019 and held it in 6 quarters.
  • Enlightenment Research's Pfizer position peaked at $1.06M in Q3 2022.
  • 3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Enlightenment Research's 13F filing for Q4 2022.